Transplantation is the treatment of choice for hepatocellular carcinoma (HCC) meeting the Milan criteria. HCC and chronic liver diseases have distinct natural histories for which an equitable transplant policy must account. We enrolled and prospectively followed at a single center 206 consecutive HC
Significance of Platelet Count in the Outcomes of Hepatectomized Patients with Hepatocellular Carcinoma Exceeding the Milan Criteria
โ Scribed by Hironobu Amano; Hirotaka Tashiro; Akihiko Oshita; Tsuyoshi Kobayashi; Yoshisato Tanimoto; Shintaro Kuroda; Hirofumi Tazawa; Toshiyuki Itamoto; Toshimasa Asahara; Hideki Ohdan
- Book ID
- 107412208
- Publisher
- Springer-Verlag
- Year
- 2011
- Tongue
- English
- Weight
- 243 KB
- Volume
- 15
- Category
- Article
- ISSN
- 1091-255X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract ## Background The aim of this systematic review was to assess the evidence on tumour downstaging before liver transplantation in patients with hepatocellular carcinoma (HCC) initially staged beyond the Milan criteria. ## Methods MEDLINE (from 1952), Embase (from 1980) and the Cochran
## BACKGROUND. Recently, it has been reported that hepatitis B virus (HBV) DNA is detected in cancerous liver tissues in some hepatitis B surface antigen negative chronic hepatitis C patients with hepatocellular carcinoma (HCC). However, the significance of HBV DNA detected in such cases remains u